Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016

Go back to Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016

Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share

November 21, 2016 7:33 AM EST

Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

... More